BIO'OR
ActiveSummary
BIO'OR has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.6m and a net result of €326,048. Equity is growing by ~14.4% per year across the filed fiscal years. Its solvency ranks better than 67% of 978 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
19-12
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2024
07-10
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
15-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
05-01
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-06
Financial
Equity above €1mEq €1.1m ▲13%
4 profitable years in a row build equity to €1.1m.
2021
14-12
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
24-02
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
30-06
Financial
Weakest financial yearnet €12,706 ▼96.9%
Net result drops to €12,706, the lowest in the series; recovery starts the following year.
28-02
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 28 days late
2019
15-02
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 15 days late
2018
23-02
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 23 days late
2016
29-12
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 8 acts read
About the unread acts
We know of 8 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.